Baxter International Inc. (BMV:BAX)
Mexico · Delayed Price · Currency is MXN 339.50
0.00 (0.00%)
At close: Jan 28, 2026
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
United States Revenue | 6.08B | 5.85B | 5.80B | |||||||||||
United States Revenue Growth | 3.93% | 0.83% | 0.57% | |||||||||||
Emerging Markets Revenue | 1.35B | 1.35B | 1.34B | |||||||||||
Emerging Markets Revenue Growth | -0.37% | 0.52% | 7.18% | |||||||||||
Rest of World Revenue | 3.60B | 3.44B | 3.22B | |||||||||||
Rest of World Revenue Growth | 4.71% | 6.87% | 5.93% | |||||||||||
Revenue (Total) | 11.02B | 10.64B | 10.36B | |||||||||||
Revenue (Total) Growth | 3.64% | 2.66% | 3.01% |
Revenue Breakdown
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Infusion Therapies Revenue | 4.06B | 4.10B | 3.96B | |||||||||||
Infusion Therapies Revenue Growth | -0.97% | 3.61% | 3.75% | |||||||||||
Advanced Surgery Revenue | 1.16B | 1.10B | 1.05B | |||||||||||
Advanced Surgery Revenue Growth | 5.25% | 5.04% | 5.31% | |||||||||||
Medical Products & Therapies Revenue | 5.23B | 5.21B | 5.01B | |||||||||||
Medical Products & Therapies Revenue Growth | 0.35% | 3.91% | 4.07% | |||||||||||
Care & Connectivity Solutions Revenue | 1.88B | 1.81B | 1.80B | |||||||||||
Care & Connectivity Solutions Revenue Growth | 3.53% | 0.78% | 0.50% | |||||||||||
Front Line Care Revenue | 1.15B | 1.14B | 1.21B | |||||||||||
Front Line Care Revenue Growth | 1.14% | -6.26% | 5.66% | |||||||||||
Healthcare Systems & Technologies Revenue | 3.03B | 2.95B | 3.01B | |||||||||||
Healthcare Systems & Technologies Revenue Growth | 2.61% | -2.06% | 2.52% | |||||||||||
Injectables and Anesthesia Revenue | 1.38B | 1.37B | 1.35B | |||||||||||
Injectables and Anesthesia Revenue Growth | 0.73% | 1.93% | 3.22% | |||||||||||
Drug Compounding Revenue | 1.09B | 1.04B | 902.00M | |||||||||||
Drug Compounding Revenue Growth | 4.53% | 15.08% | 9.87% | |||||||||||
Pharmaceuticals Revenue | 2.47B | 2.41B | 2.25B | |||||||||||
Pharmaceuticals Revenue Growth | 2.36% | 7.20% | 5.79% | |||||||||||
Other Revenue (Post-Q2 2023 Reporting) | 302.00M | 67.00M | 87.00M | |||||||||||
Other Revenue (Post-Q2 2023 Reporting) Growth | 350.75% | -22.99% | -50.85% | |||||||||||
Revenue (Total) | 11.02B | 10.64B | 10.36B | |||||||||||
Revenue (Total) Growth | 3.64% | 2.66% | 3.01% |
EBIT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Medical Products & Therapies Operating Income | 973.00M | 950.00M | 972.00M | |||||||||||
Medical Products & Therapies Operating Income Growth | 2.42% | -2.26% | 1.04% | |||||||||||
Healthcare Systems & Technologies Operating Income | 460.00M | 468.00M | 483.00M | |||||||||||
Healthcare Systems & Technologies Operating Income Growth | -1.71% | -3.11% | -2.23% | |||||||||||
Pharmaceuticals Operating Income | 285.00M | 313.00M | 401.00M | |||||||||||
Pharmaceuticals Operating Income Growth | -8.95% | -21.95% | 2.56% | |||||||||||
Other Operating Income | 23.00M | 18.00M | 18.00M | |||||||||||
Other Operating Income Growth | 27.78% | - | -76.62% | |||||||||||
Operating Income (Total) | 411.00M | 14.00M | 707.00M | |||||||||||
Operating Income (Total) Growth | 2835.71% | -98.02% | - |
Updated Sep 30, 2025. Data Source: Fiscal.ai.